MiR-101: a potential therapeutic target of cancers

MicroRNAs (miRNAs) are small noncoding RNAs that could regulate gene expressions transcriptionally or post-transcriptionally through binding to 3' untranslated region (3'UTR) of target messenger RNAs (mRNAs), which were identified to be associated with tumorigenesis in various neoplasms. A...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of translational research Vol. 10; no. 11; pp. 3310 - 3321
Main Authors Wang, Cen-Zhu, Deng, Fei, Li, Hao, Wang, Dan-Dan, Zhang, Wei, Ding, Li, Tang, Jin-Hai
Format Journal Article
LanguageEnglish
Published United States e-Century Publishing Corporation 01.01.2018
Subjects
Review
cancers
therapeutic targets
biomarker
miR-101
Online AccessGet full text

Cover

More Information
Summary:MicroRNAs (miRNAs) are small noncoding RNAs that could regulate gene expressions transcriptionally or post-transcriptionally through binding to 3' untranslated region (3'UTR) of target messenger RNAs (mRNAs), which were identified to be associated with tumorigenesis in various neoplasms. Among them, miR-101, encoded by two precursor transcripts (miR-101-1 and miR-101-2), was recognized to serve as a tumor suppressor via targeting critical oncogenes or anti-oncogenes. Additionally, studies have shown that miR-101 was participated in multiple cancer-related biological processes, including proliferation, apoptosis, angiogenesis, drug resistance, invasion and metastasis. In this review, we aim to summarize the function of miR-101 in different biological processes by figuring out the underlying target gene networks and explore its potential role as a biomarker in diverse neoplasms, which will provide a brand-new insight in molecular targeting cancer treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Equal contributors.
ISSN:1943-8141
1943-8141